Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review

Sima Habibi, Majid Zaki-Dizaji, Hosein Rafiemanesh, Bernice Lo, Mahnaz Jamee, Laura Gámez-Díaz, Fereshte Salami, Ali N. Kamali, Hamed Mohammadi, Hassan Abolhassani, Reza Yazdani, Asghar Aghamohammadi, Juan Manuel Anaya, Gholamreza Azizi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary immunodeficiency and immune dysregulation syndrome caused by biallelic mutations in the LRBA gene. These mutations usually abrogate the protein expression of LRBA, leading to a broad spectrum of clinical phenotypes including autoimmunity, chronic diarrhea, hypogammaglobulinemia, and recurrent infections. Objective: Our aim was to systematically collect all studies reporting on the clinical manifestations, molecular and laboratory findings, and management of patients with LRBA deficiency. Methods: We searched in PubMed, Web of Science, and Scopus without any restrictions on study design and publication time. A total of 109 LRBA-deficient cases were identified from 45 eligible articles. For all patients, demographic information, clinical records, and immunologic and molecular data were collected. Results: Of the patients with LRBA deficiency, 93 had homozygous and 16 had compound heterozygous mutations in LRBA. The most common clinical manifestations were autoimmunity (82%), enteropathy (63%), splenomegaly (57%), and pneumonia (49%). Reduction in numbers of CD4 + T cells and regulatory T cells as well as IgG levels was recorded for 21.6%, 65.6%, and 54.2% of evaluated patients, respectively. B-cell subpopulation analysis revealed low numbers of switched-memory and increased numbers of CD21 low B cells in 73.5% and 77.8% of patients, respectively. Eighteen (16%) patients underwent hematopoietic stem cell transplantation due to the severity of complications and the outcomes improved in 13 of them. Conclusions: Autoimmune disorders are the main clinical manifestations of LRBA deficiency. Therefore, LRBA deficiency should be included in the list of monogenic autoimmune diseases, and screening for LRBA mutations should be routinely performed for patients with these conditions.

Original languageEnglish
JournalJournal of Allergy and Clinical Immunology: In Practice
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Protein Deficiency
Mutation
Proteins
Autoimmunity
B-Lymphocytes
Agammaglobulinemia
Hematopoietic Stem Cell Transplantation
Splenomegaly
Regulatory T-Lymphocytes
PubMed
Autoimmune Diseases
Publications
Diarrhea
Pneumonia
Immunoglobulin G
Demography
T-Lymphocytes
Phenotype
Infection

Keywords

  • Autoimmunity
  • Enteropathy
  • Hematopoietic stem cell transplantation
  • LRBA deficiency
  • Polyautoimmunity
  • Regulatory T cell

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency : A Systematic Review. / Habibi, Sima; Zaki-Dizaji, Majid; Rafiemanesh, Hosein; Lo, Bernice; Jamee, Mahnaz; Gámez-Díaz, Laura; Salami, Fereshte; Kamali, Ali N.; Mohammadi, Hamed; Abolhassani, Hassan; Yazdani, Reza; Aghamohammadi, Asghar; Anaya, Juan Manuel; Azizi, Gholamreza.

In: Journal of Allergy and Clinical Immunology: In Practice, 01.01.2019.

Research output: Contribution to journalArticle

Habibi, S, Zaki-Dizaji, M, Rafiemanesh, H, Lo, B, Jamee, M, Gámez-Díaz, L, Salami, F, Kamali, AN, Mohammadi, H, Abolhassani, H, Yazdani, R, Aghamohammadi, A, Anaya, JM & Azizi, G 2019, 'Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review', Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2019.04.011
Habibi, Sima ; Zaki-Dizaji, Majid ; Rafiemanesh, Hosein ; Lo, Bernice ; Jamee, Mahnaz ; Gámez-Díaz, Laura ; Salami, Fereshte ; Kamali, Ali N. ; Mohammadi, Hamed ; Abolhassani, Hassan ; Yazdani, Reza ; Aghamohammadi, Asghar ; Anaya, Juan Manuel ; Azizi, Gholamreza. / Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency : A Systematic Review. In: Journal of Allergy and Clinical Immunology: In Practice. 2019.
@article{c71625660d6640f68a9409c7dc250973,
title = "Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review",
abstract = "Background: LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary immunodeficiency and immune dysregulation syndrome caused by biallelic mutations in the LRBA gene. These mutations usually abrogate the protein expression of LRBA, leading to a broad spectrum of clinical phenotypes including autoimmunity, chronic diarrhea, hypogammaglobulinemia, and recurrent infections. Objective: Our aim was to systematically collect all studies reporting on the clinical manifestations, molecular and laboratory findings, and management of patients with LRBA deficiency. Methods: We searched in PubMed, Web of Science, and Scopus without any restrictions on study design and publication time. A total of 109 LRBA-deficient cases were identified from 45 eligible articles. For all patients, demographic information, clinical records, and immunologic and molecular data were collected. Results: Of the patients with LRBA deficiency, 93 had homozygous and 16 had compound heterozygous mutations in LRBA. The most common clinical manifestations were autoimmunity (82{\%}), enteropathy (63{\%}), splenomegaly (57{\%}), and pneumonia (49{\%}). Reduction in numbers of CD4 + T cells and regulatory T cells as well as IgG levels was recorded for 21.6{\%}, 65.6{\%}, and 54.2{\%} of evaluated patients, respectively. B-cell subpopulation analysis revealed low numbers of switched-memory and increased numbers of CD21 low B cells in 73.5{\%} and 77.8{\%} of patients, respectively. Eighteen (16{\%}) patients underwent hematopoietic stem cell transplantation due to the severity of complications and the outcomes improved in 13 of them. Conclusions: Autoimmune disorders are the main clinical manifestations of LRBA deficiency. Therefore, LRBA deficiency should be included in the list of monogenic autoimmune diseases, and screening for LRBA mutations should be routinely performed for patients with these conditions.",
keywords = "Autoimmunity, Enteropathy, Hematopoietic stem cell transplantation, LRBA deficiency, Polyautoimmunity, Regulatory T cell",
author = "Sima Habibi and Majid Zaki-Dizaji and Hosein Rafiemanesh and Bernice Lo and Mahnaz Jamee and Laura G{\'a}mez-D{\'i}az and Fereshte Salami and Kamali, {Ali N.} and Hamed Mohammadi and Hassan Abolhassani and Reza Yazdani and Asghar Aghamohammadi and Anaya, {Juan Manuel} and Gholamreza Azizi",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jaip.2019.04.011",
language = "English",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",

}

TY - JOUR

T1 - Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency

T2 - A Systematic Review

AU - Habibi, Sima

AU - Zaki-Dizaji, Majid

AU - Rafiemanesh, Hosein

AU - Lo, Bernice

AU - Jamee, Mahnaz

AU - Gámez-Díaz, Laura

AU - Salami, Fereshte

AU - Kamali, Ali N.

AU - Mohammadi, Hamed

AU - Abolhassani, Hassan

AU - Yazdani, Reza

AU - Aghamohammadi, Asghar

AU - Anaya, Juan Manuel

AU - Azizi, Gholamreza

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary immunodeficiency and immune dysregulation syndrome caused by biallelic mutations in the LRBA gene. These mutations usually abrogate the protein expression of LRBA, leading to a broad spectrum of clinical phenotypes including autoimmunity, chronic diarrhea, hypogammaglobulinemia, and recurrent infections. Objective: Our aim was to systematically collect all studies reporting on the clinical manifestations, molecular and laboratory findings, and management of patients with LRBA deficiency. Methods: We searched in PubMed, Web of Science, and Scopus without any restrictions on study design and publication time. A total of 109 LRBA-deficient cases were identified from 45 eligible articles. For all patients, demographic information, clinical records, and immunologic and molecular data were collected. Results: Of the patients with LRBA deficiency, 93 had homozygous and 16 had compound heterozygous mutations in LRBA. The most common clinical manifestations were autoimmunity (82%), enteropathy (63%), splenomegaly (57%), and pneumonia (49%). Reduction in numbers of CD4 + T cells and regulatory T cells as well as IgG levels was recorded for 21.6%, 65.6%, and 54.2% of evaluated patients, respectively. B-cell subpopulation analysis revealed low numbers of switched-memory and increased numbers of CD21 low B cells in 73.5% and 77.8% of patients, respectively. Eighteen (16%) patients underwent hematopoietic stem cell transplantation due to the severity of complications and the outcomes improved in 13 of them. Conclusions: Autoimmune disorders are the main clinical manifestations of LRBA deficiency. Therefore, LRBA deficiency should be included in the list of monogenic autoimmune diseases, and screening for LRBA mutations should be routinely performed for patients with these conditions.

AB - Background: LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary immunodeficiency and immune dysregulation syndrome caused by biallelic mutations in the LRBA gene. These mutations usually abrogate the protein expression of LRBA, leading to a broad spectrum of clinical phenotypes including autoimmunity, chronic diarrhea, hypogammaglobulinemia, and recurrent infections. Objective: Our aim was to systematically collect all studies reporting on the clinical manifestations, molecular and laboratory findings, and management of patients with LRBA deficiency. Methods: We searched in PubMed, Web of Science, and Scopus without any restrictions on study design and publication time. A total of 109 LRBA-deficient cases were identified from 45 eligible articles. For all patients, demographic information, clinical records, and immunologic and molecular data were collected. Results: Of the patients with LRBA deficiency, 93 had homozygous and 16 had compound heterozygous mutations in LRBA. The most common clinical manifestations were autoimmunity (82%), enteropathy (63%), splenomegaly (57%), and pneumonia (49%). Reduction in numbers of CD4 + T cells and regulatory T cells as well as IgG levels was recorded for 21.6%, 65.6%, and 54.2% of evaluated patients, respectively. B-cell subpopulation analysis revealed low numbers of switched-memory and increased numbers of CD21 low B cells in 73.5% and 77.8% of patients, respectively. Eighteen (16%) patients underwent hematopoietic stem cell transplantation due to the severity of complications and the outcomes improved in 13 of them. Conclusions: Autoimmune disorders are the main clinical manifestations of LRBA deficiency. Therefore, LRBA deficiency should be included in the list of monogenic autoimmune diseases, and screening for LRBA mutations should be routinely performed for patients with these conditions.

KW - Autoimmunity

KW - Enteropathy

KW - Hematopoietic stem cell transplantation

KW - LRBA deficiency

KW - Polyautoimmunity

KW - Regulatory T cell

UR - http://www.scopus.com/inward/record.url?scp=85065612257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065612257&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2019.04.011

DO - 10.1016/j.jaip.2019.04.011

M3 - Article

C2 - 30995531

AN - SCOPUS:85065612257

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

ER -